Cargando…

The use of anti-GITR antibody treatment in a murine model of glioblastoma multiforme

Detalles Bibliográficos
Autores principales:	Miska, Jason, Chang, Alan L, Rashidi, Aida, Dey, Mahua, Han, Yu, Zhang, Lingjiao, Balyasnikova, Irina V, Ahmed, Atique U, Lesniak, Maciej S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649309/ http://dx.doi.org/10.1186/2051-1426-3-S2-P236

Ejemplares similares

Glioma microenvironment-derived CCL2 recruits regulatory T cells and myeloid-derived suppressor cells
por: Chang, Alan L, et al.
Publicado: (2015)

Neural Stem Cell Carriers for the Treatment of Glioblastoma Multiforme
por: Miska, Jason, et al.
Publicado: (2015)

A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model
por: Kim, Julius W., et al.
Publicado: (2017)

Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
por: Dey, Mahua, et al.
Publicado: (2016)

Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer
por: Cordero, Alex, et al.
Publicado: (2021)

Pharmacodynamic analysis of an agonistic antibody to the costimulatory receptor GITR
por: Moody, Gordon, et al.
Publicado: (2015)

Temozolomide Treatment Increases Fatty Acid Uptake in Glioblastoma Stem Cells
por: Caragher, Seamus, et al.
Publicado: (2020)

Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas
por: Amoozgar, Zohreh, et al.
Publicado: (2021)

HIF-1α Is a Metabolic Switch between Glycolytic-Driven Migration and Oxidative Phosphorylation-Driven Immunosuppression of Tregs in Glioblastoma
por: Miska, Jason, et al.
Publicado: (2019)

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
por: Patel, Mira, et al.
Publicado: (2015)

STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma
por: Zhang, Peng, et al.
Publicado: (2023)

Activation of 4-1BBL(+) B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma
por: Lee-Chang, Catalina, et al.
Publicado: (2020)

Murinization of an anti-GITR IgG2c antibody DTA-1 inhibits immunogenicity-mediated anaphylaxis in C57BL/6J mice
por: Alvarez, Hamsell, et al.
Publicado: (2015)

Charachterization and functional analysis of scFv-based CARs to redirect T cells to IL13Rα2-positive glioma
por: Krenciute, Giedre, et al.
Publicado: (2015)

A genetic survival network for glioblastoma multiforme
por: Lin, Andy, et al.
Publicado: (2011)

Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)

Murine B Cell Development and Antibody Responses to Model Antigens Are Not Impaired in the Absence of the TNF Receptor GITR
por: Sinik Teodorovic, Lenka, et al.
Publicado: (2012)

An Update in the Use of Antibodies to Treat Glioblastoma Multiforme
por: Hernández-Pedro, Norma Y., et al.
Publicado: (2013)

Mesenchymal Stem Cells Modified with a Single-Chain Antibody against EGFRvIII Successfully Inhibit the Growth of Human Xenograft Malignant Glioma
por: Balyasnikova, Irina V., et al.
Publicado: (2010)

Targeting Tregs in Malignant Brain Cancer: Overcoming IDO
por: Wainwright, Derek A., et al.
Publicado: (2013)

Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012)

A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors
por: Kim, Julius W., et al.
Publicado: (2015)

Targeted multi-epitope therapeutic vaccine for the treatment of invasive glioblastoma multiforme
por: Huang, Xiaofang, et al.
Publicado: (2015)

Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
por: Patel, Mira A., et al.
Publicado: (2016)

Fatty Acid Uptake in T Cell Subsets Using a Quantum Dot Fatty Acid Conjugate
por: Muroski, Megan E., et al.
Publicado: (2017)

Interleukin-8/CXCR2 signaling regulates therapy-induced plasticity and enhances tumorigenicity in glioblastoma
por: Hasan, Tanwir, et al.
Publicado: (2019)

Erratum to: Agonist anti-GITR monoclonal antibody and stereotactic radiation induce immune-mediated survival advantage in murine intracranial glioma
por: Patel, Mira A., et al.
Publicado: (2016)

Incidentalomas to glioblastoma multiforme
por: Sachdev, Bobby, et al.
Publicado: (2014)

Impairment of Treg suppression by GITR ligation is effective selectively in the context of a pro-inflammatory tumor microenvironment
por: Zappasodi, Roberta, et al.
Publicado: (2014)

Pharmacologic modulation of nasal epithelium augments neural stem cell targeting of glioblastoma
por: Spencer, Drew, et al.
Publicado: (2019)

CD8(+) T Cells: GITR Matters
por: Ronchetti, Simona, et al.
Publicado: (2012)

Enhanced immunotherapy by combining a vaccine with a novel murine GITR ligand fusion protein
por: Morillon, Y. Maurice, et al.
Publicado: (2017)

Optimal target saturation of ligand-blocking anti-GITR antibody IBI37G5 dictates FcγR-independent GITR agonism and antitumor activity
por: Liu, Huisi, et al.
Publicado: (2022)

An anti-PD-1–GITR-L bispecific agonist induces GITR clustering-mediated T cell activation for cancer immunotherapy
por: Chan, Sarah, et al.
Publicado: (2022)

Tectal plate glioblastoma multiforme
por: Nemer, Michael D., et al.
Publicado: (2011)

Bilateral cystic glioblastoma multiforme
por: Kumar, Sushil, et al.
Publicado: (2013)

Glioblastoma Multiforme Stem Cells
por: Dimov, Irena, et al.
Publicado: (2011)

Atypical Presentation of Glioblastoma Multiforme
por: Al-Janabi, Wissam, et al.
Publicado: (2018)

Nanotechnology for Treatment of Glioblastoma Multiforme
por: Michael, Justin S., et al.
Publicado: (2018)

The complement system in glioblastoma multiforme
por: Bouwens van der Vlis, T. A. M., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_115q1jog5kolo23te73iiobkmu